Literature DB >> 34341597

Multiple myeloma and primary erythrocytosis in a dog.

Marianna Ricci1, Giulia De Feo1, Martin Konar1, George Lubas1.   

Abstract

A 13-year-old spayed female mixed breed dog was referred for impaired ambulation, limb tremors, back pain, hypergammaglobulinemia on cellulose acetate electrophoresis, and mild proteinuria. Conventional radiology and magnetic resonance imaging (MRI) suggested multifocal neoplastic bone lesions. At the referral examination, lameness and bright red mucous membranes were observed. Severe erythrocytosis, a monoclonal peak in the β-2 globulin detected by capillary zone electrophoresis, severe proteinuria, bone marrow infiltration of plasma cells, and low serum erythropoietin concentrations were reported. The final diagnosis was multiple myeloma associated with severe primary erythrocytosis. This presentation in a dog is interesting because the combination of both disorders is rare in humans and has not been reported in dogs. Key clinical message: Although rare, multiple myeloma and primary erythrocytosis can occur together in dogs. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2021        PMID: 34341597      PMCID: PMC8281951     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  19 in total

1.  Multiple myeloma associated with polycythemia; report of four cases.

Authors:  J H LAWRENCE; R L ROSENTHAL
Journal:  Am J Med Sci       Date:  1949-08       Impact factor: 2.378

2.  Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P Moreau; J San Miguel; P Sonneveld; M V Mateos; E Zamagni; H Avet-Loiseau; R Hajek; M A Dimopoulos; H Ludwig; H Einsele; S Zweegman; T Facon; M Cavo; E Terpos; H Goldschmidt; M Attal; C Buske
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

3.  The TEMPI syndrome.

Authors:  David B Sykes; Casey O'Connell; Wilfried Schroyens
Journal:  Blood       Date:  2020-04-09       Impact factor: 22.113

4.  Concurrence of multiple myeloma and idiopathic erythrocytosis.

Authors:  H Chang; L Y Shih
Journal:  Acta Clin Belg       Date:  2009 Sep-Oct       Impact factor: 1.264

Review 5.  The role of JAK inhibitors in multiple myeloma.

Authors:  Matthew Ghermezi; Tanya M Spektor; James R Berenson
Journal:  Clin Adv Hematol Oncol       Date:  2019-09

6.  Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist.

Authors:  Flavia G Rosado; Jennifer L Oliveira; Aliya R Sohani; Wilfried Schroyens; David B Sykes; Saad S Kenderian; Martha Q Lacy; Robert A Kyle; James D Hoyer
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

7.  Prognostic factors for multiple myeloma in the dog.

Authors:  R E Matus; C E Leifer; E G MacEwen; A I Hurvitz
Journal:  J Am Vet Med Assoc       Date:  1986-06-01       Impact factor: 1.936

8.  Unusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder.

Authors:  J Maerki; G Katava; D Siegel; J Silberberg; P K Bhattacharyya
Journal:  Case Rep Hematol       Date:  2014-10-15

Review 9.  Polycythemia Vera-Associated Complications: Pathogenesis, Clinical Manifestations, And Effects On Outcomes.

Authors:  Danielle Cuthbert; Brady Lee Stein
Journal:  J Blood Med       Date:  2019-10-18

10.  Concurrent Polycythemia of Undetermined Etiology and Smouldering Plasma Cell Myeloma.

Authors:  Roula Katerji; Chad A Hudson
Journal:  Case Rep Pathol       Date:  2018-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.